Mark Quick

Mark Quick

Directeur/Membre du Conseil chez NANOLOGICA AB
60 ans
Health Technology
Miscellaneous
Consumer Services

Profil

Mr. Mark R.
Quick is a Partner at Flerie Invest AB and a Member-Management Board & Partner at Flerie AB. He is on the Board of Directors at Nanologica AB, Recipharm HC Ltd., Aesica Formulation Development Ltd., Aesica Holdco Ltd., Binx Health Ltd., Recipharm Fontaine SAS, Recipharm Holdings Ltd., Recipharm Parets SL and Wasserburger Arzneimittelwerk GmbH.
Mr. Quick was previously employed as a Head-Corporate Development by Recipharm AB, a Head-Business Development by Celltech Manufacturing Services Ltd., an Account Manager by Medeva Pharma SA, a Demand Manager by Celltech Pharmaceuticals Ltd., and an Area Manager-Overseas Department by ICI Chemicals & Polymers Ltd. He also served on the board at Recipharm Ltd., Consort Medical Ltd. and Recipharm Monts SAS. He received his undergraduate degree from Nottingham Trent University and an MBA from The Open University Business School.

Postes actifs de Mark Quick

SociétésPosteDébut
FLERIE INVEST AB Corporate Officer/Principal 01/01/2022
NANOLOGICA AB Directeur/Membre du Conseil 21/05/2026
Directeur/Membre du Conseil 04/02/2020
Private Equity Investor 01/03/2022
Directeur/Membre du Conseil 03/05/2018
Directeur/Membre du Conseil 25/02/2021
Directeur/Membre du Conseil 15/06/2020
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Mark Quick

SociétésPosteFin
░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Mark Quick

Formation de Mark Quick

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

17

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées21

Miscellaneous

Process Industries

Consumer Services

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Miscellaneous

Health Technology

  1. Bourse
  2. Insiders
  3. Mark Quick
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇